PTK2 and gastric cancer: Collectively, evodiamine inhibits growth of gastric cancer cells by inducing apoptosis, which might be mediated by activation of caspases and inhibition of mitochondrial apoptosis-related proteins, the FAK/AKT/mTOR pathway, and STAT3 signaling.